The reduced expression of selected ATG genes/proteins, e.g., ATG5 protein [17], ATG2B [43] in CRC vs. control tissue, is shown to correlate with lymphovascular invasion [17] or the infiltration of CD8+ and CD4+ T cells, B cells and T cell receptor signaling pathways [43]. The gene discussed is ATG5; the disease is colorectal carcinoma.